Claire Brooks
MSc Medical Statistics
Pharmacovigilance Manager
- Previously: Portfolio Lead, Radiotherapy & Imaging Trials, Patient and Public Involvement Coordinator
Recent publications
-
A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio.
Journal article
Mulholland PJ. et al, (2023), Journal of Clinical Oncology, 41, LBA2023 - LBA2023
-
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.
Journal article
Brown NF. et al, (2020), BMC Cancer, 20
-
Cytosponge™ for post-chemoradiation surveillance of oesophageal cancer: a feasibility study.
Conference paper
Levy S. et al, (2019), Ann Oncol, 30 Suppl 4
-
Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study.
Journal article
Carpenter LM. et al, (2009), BMJ (Clinical research ed.), 338
-
Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study.
Journal article
Venables KM. et al, (2009), BMJ (Clinical research ed.), 338
-
Cancer morbidity in british military veterans included in chemical warfare agent experiments at porton down: Cohort study
Journal article
Carpenter LM. et al, (2009), BMJ (Online), 338
-
Mortality in british military participants in human experimental research into chemical warfare agents at Porton Down: Cohort study
Journal article
Venables KM. et al, (2009), BMJ (Online), 338
-
Management of women who test positive for high-risk types of human papillomavirus: the HART study.
Journal article
Cuzick J. et al, (2003), Lancet, 362, 1871 - 1876